Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Sep 16;226(4):595–607. doi: 10.1093/infdis/jiaa586

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

PMC Copyright notice

Figure 2. — Anti–Ebola virus glycoprotein immunoglobulin G binding antibody responses after heterologous or homologous 2-dose vaccination with Ad26.ZEBOV (adenovirus serotype 26 [Ad26]) and/or MVA-BN-Filo (modified vaccinia Ankara [MVA]) and booster vaccination at day 360 for groups 1–4 (A), 5 and 6 (B), 7 and 8 (C), and 9 and 10 (no booster vaccinations) (D). Vaccination regimens are shown as “dose 1, dose 2 (booster).” Responses represent geometric mean concentrations with 95% confidence intervals. Abbreviations: EU, enzyme-linked immunosorbent assay units; hdAd26, high-dose Ad26; hdMVA, high-dose MVA.